Research, rank and track

The world's most practical peptide knowledge base.

Understand peptides before everyone else. Compare evidence, source trails, frontier signals, and private tracker notes without living inside twenty tabs and forum threads.

217 peptide cards Source-linked summaries No vendor links Educational reference
Secret Lab preview
Peptide Dex preview
★★★★★

"Finally, peptide research without the noise."

217Peptide cards organized by goal, category, evidence, and frontier interest.
0Vendor links. No supplement-store energy, no vial sales, no affiliate pressure.
8Research lenses for evidence, popularity, source quality, status, and safety context.
1Place to research, compare, save, and track what matters to you.
Frontier Research Feed

A preview of what is moving in peptide research.

The public feed gives the signal. The app gives the full analysis, source trail, ranking context, and what changed.

Metabolic research

Muscle preservation pathways are getting more attention

The peptide conversation is moving from simple weight-loss narratives toward lean-mass preservation, adherence, and long-term outcomes.

Read full analysis in app
Recovery

Recovery peptides remain high-interest but low-certainty

BPC-157 and TB-500 dominate search volume, but users need clearer separation between animal data, human data, and anecdotes.

Read full analysis in app
Longevity

Mitochondrial peptides are entering the mainstream watchlist

MOTS-c and SS-31 sit at the intersection of metabolism, aging biology, and energy systems research.

Read full analysis in app
Evidence

Source quality is becoming the real ranking signal

People are learning that 'most talked about' and 'best supported' are not the same ranking.

Read full analysis in app
Weekly Peptide Spotlight

BPC-157: the recovery peptide everyone talks about.

High attention does not automatically mean strong human evidence. This is exactly where the app is useful.

Mechanism lensTissue-repair signaling and gut-derived peptide biology are the common research themes.
Potential research areasRecovery, tendon and joint discussions, gut-related preclinical studies.
Current research statusMostly preclinical, with human certainty much thinner than the internet implies.
Key considerationAttention ranking and evidence ranking are different things.
Locked in app

Curiosity gap, on purpose.

You get enough context to know what matters. The deeper answer lives in the app.

Full source trail with every claim mapped to the original paper.
Rank explanation: hype, evidence, frontier score, and category context.
Comparison matrix against TB-500 and other recovery entries.
Private research notes and tracker templates.

Open Full Card In App

Interactive Peptide Explorer

Search the public index. Unlock the useful layers in app.

The website shows a clean overview, category, and research stage. The app unlocks comparison, saved notes, tracker links, and source context.

BPC-157

One of the most-discussed recovery peptides online. Public interest is high, but the evidence base is still mostly animal and lab research, which makes source context essential.

Recovery

TB-500

Frequently compared with BPC-157 in recovery conversations, but it is a different research story with different mechanisms and evidence gaps.

Recovery

MOTS-c

A mitochondrial-derived peptide that draws attention from longevity and metabolic-health circles because it sits close to energy regulation research.

Longevity

SS-31

Also known as elamipretide, SS-31 is commonly discussed in mitochondrial medicine and aging biology because it targets cellular energy systems.

Longevity

Semaglutide

A GLP-1 receptor agonist with a large human evidence base and massive public attention in metabolic-health and weight-management discussions.

Metabolic

Retatrutide

A high-attention investigational multi-agonist in metabolic research. It attracts interest because it sits at the frontier of incretin science.

Metabolic

Tesamorelin

A growth-hormone-releasing hormone analog with a more established clinical context than many peptides discussed online.

Metabolic

GHK-Cu

A copper peptide commonly discussed around skin, hair, and wound-healing research, with broad consumer interest and varied evidence quality.

Skin and hair

Epitalon

A longevity-associated peptide with persistent online interest and a complicated research story that deserves careful source review.

Longevity

CJC-1295 + Ipamorelin

A frequently searched pairing in growth-hormone secretagogue conversations, often mentioned by clinics and optimization communities.

Hormonal
Longevity Dashboard Preview

Browse by the biological system you actually care about.

Recovery, muscle, metabolic health, sleep, cognition, skin, and longevity all connect to different evidence maps. The app keeps them separate.

Dex screenshot
Peptide detail screenshot
Evidence screenshot
Secret Lab screenshot
Tracker screenshot
Research Library

Enough to learn. Not enough to stop.

Public pages reveal titles, plain-English summaries, and research categories. Expert interpretation, ranking context, and tracker actions stay app-exclusive.

Recovery

BPC-157: research stage

One of the most-discussed recovery peptides online. Public interest is high, but the evidence base is still mostly animal and lab research, which makes source context essential.

Open public brief
Recovery

TB-500: research stage

Frequently compared with BPC-157 in recovery conversations, but it is a different research story with different mechanisms and evidence gaps.

Open public brief
Longevity

MOTS-c: research stage

A mitochondrial-derived peptide that draws attention from longevity and metabolic-health circles because it sits close to energy regulation research.

Open public brief
Longevity

SS-31: research stage

Also known as elamipretide, SS-31 is commonly discussed in mitochondrial medicine and aging biology because it targets cellular energy systems.

Open public brief
Metabolic

Semaglutide: research stage

A GLP-1 receptor agonist with a large human evidence base and massive public attention in metabolic-health and weight-management discussions.

Open public brief
Metabolic

Retatrutide: research stage

A high-attention investigational multi-agonist in metabolic research. It attracts interest because it sits at the frontier of incretin science.

Open public brief
Research Map Teasers

Research maps, not medical instructions.

Each pathway is framed as education and organization. The app helps you compare, save, and track user-entered plans.

Recovery Research Map

Start with injury context, evidence quality, and source type.

  1. Identify the mechanism family.
  2. Separate human data from animal data.
  3. Compare BPC-157, TB-500, and adjacent entries.
  4. Full map in app.

Fat Loss Research Map

Compare metabolic entries by approval status and evidence depth.

  1. Start with GLP-1 and incretin context.
  2. Check human evidence and warnings.
  3. Compare approved and investigational entries.
  4. Full map in app.

Longevity Research Map

Organize mitochondrial, senolytic, and repair-related claims.

  1. Classify the biological system.
  2. Read the source quality first.
  3. Track unanswered questions.
  4. Full map in app.

Performance Research Map

Keep hype, regulatory status, and human evidence separate.

  1. Define the performance goal.
  2. Compare evidence and status.
  3. Save the entries you want to monitor.
  4. Full map in app.
Peptide Comparisons

The fastest way to find what you do not know yet.

Quick public comparison. Full app matrix with evidence, category, stage, source quality, and saved notes.

Comparison

BPC-157 vs TB-500

Two recovery favorites, two very different research maps.

Full evidence matrix, safety notes, and source trail live inside the app.
Comparison

MOTS-c vs SS-31

Mitochondrial signaling versus mitochondrial membrane targeting.

Full evidence matrix, safety notes, and source trail live inside the app.
Comparison

CJC-1295 vs Ipamorelin

Often discussed together, but not the same mechanism story.

Full evidence matrix, safety notes, and source trail live inside the app.
Comparison

Semaglutide vs Retatrutide

Approved GLP-1 evidence versus investigational multi-agonist attention.

Full evidence matrix, safety notes, and source trail live inside the app.
Why people use it

It turns scattered peptide research into a system.

Save hundreds of hours

Stop re-reading the same forum threads and start from organized evidence context.

Understand research faster

Each card separates mechanism, evidence, attention, stage, and source quality.

Avoid misinformation

Hype rank and evidence rank are deliberately kept apart.

Track frontier changes

Save entries, watch emerging compounds, and keep private notes in one place.